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Abstract 
There exists the intention to shift pharmaceutical manufacturing of solid dosage forms from 
traditional batch production towards continuous production. The currently applied conventional 
quality control systems, based on sampling and time-consuming off-line analyses in analytical 
laboratories, would annul the advantages of continuous processing. It is clear that real-time quality 
assessment and control is indispensable for continuous production. This manuscript evaluates 
strengths and weaknesses of several complementary Process Analytical Technology (PAT) tools 
implemented in a continuous wet granulation process, which is part of a fully continuous from 
powder-to-tablet production line. The use of Raman and NIR spectroscopy and a particle size 
distribution analyzer is evaluated for the real-time monitoring of critical parameters during the 
continuous wet agglomeration of an anhydrous theophylline – lactose blend.  The solid state 
characteristics and particle size of the granules were analyzed in real-time and the critical process 
parameters influencing these granule characteristics were identified. The temperature of the 
granulator barrel, the amount of granulation liquid added and, to a lesser extent, the powder feed 
rate were the parameters influencing the solid state of the active pharmaceutical ingredient (API). A 
higher barrel temperature and a higher powder feed rate, resulted in larger granules. 
 
 
 
 
 
 
 
Introduction 
Continuous processing is well established in the chemical, cosmetical and food industry, whilst it is 
still in its infancy in the pharmaceutical industry. Pharmaceutical companies stick to batch 
processing, because the machinery required for batch processing is already installed in their 
production plants. A switch to continuous production would require investments in new equipment, 
training of the employees, new process validation and co-current regulatory documentation. 
However, batch processing is a very time-consuming and expensive way of production, which can be 
overcome by continuous production. For example, the development process of solid dosage forms is 
generally accomplished by the optimization of its production at several batch scales: first, the 
product is formulated at lab-scale, after which pilot and clinical batches are produced, followed by 
production scale manufacturing. This up-scaling process is not only costly and time-consuming; it 
also prolongs the time-to-the-market. Process optimization and validation have to be performed at 
each batch scale since optimal process and formulation settings at small scale process are generally 
not transferrable to larger scales [1]. Up-scaling does also involve regulatory issues, because larger 
batches may require new bioequivalence tests, next to dissolution and stability-tests [2]. 
Alternatively, continuous production processing allows flexible batch sizes as larger amounts of drug 
products can be produced by simply running the process longer using the same process equipment. 
(i.e. “up-scaling in the fourth dimension” [3]).  Hence, continuous manufacturing can lead to just-in-
time production, where products do not longer have to wait in warehouses. Furthermore, 
continuous manufacturing lines aim to be fully automated with a minimum of operators, as material 
transport to the next production step is integrated in the production line.  Since pharmaceutical 
manufacturers are under increasing pressure to reduce expenses and augment efficiency, 
continuous manufacturing will also have an economical impact.  
One of the major reasons for the pharmaceutical industry to be reluctant to move from batch 
production to continuous production, is the uncertainty of approval by the regulatory bodies. 
Indeed, the drug quality and safety have to be assessed and assured at any time. Batch production 
works with the principle of profound product quality control, by means of sampling and testing after 
each step in the production process. It is obvious that the current conventional quality control 
systems of production processes, based on off-line analyses in analytical laboratories, would annul 
the advantages of continuous processing. Real-time quality evaluation and control, using in-line 
process analyzers, is crucial for the successful implementation of continuous manufacturing of 
pharmaceutical products.  
Based on the Process Analytical Technology (PAT) -guidance for Industry [4], the Process Validation 
Guidance for Industry [5] and the ICH guidelines Q8, Q9 and Q10 [6-8], a new approach for 
pharmaceutical development and production has been proposed. In the PAT-guidance, the FDA 
encourages the industry to improve pharmaceutical development, manufacturing and quality 
assurance through innovation in product and process development, process analysis and process 
control by using the latest scientific advances. The aim is to ensure product quality through the 
design of effective manufacturing processes, where formulation and process factors and their 
influence on the end-product are fully understood. This profound understanding and control of 
manufacturing processes must lead to quality built into the product (Quality by Design). The desire 
within the pharmaceutical industry to shift towards continuous processing strengthens the need to 
invest in PAT. The recently introduced Guidance for Process Validation [5] focuses on assuring drug 
quality by effective process validation. A manufacturing process must be capable of consistently 
delivering a high quality product. The scientific evidence of that should be based on the collection 
and evaluation of data, from the process design stage through the commercial production. In the ICH 
Q8 guideline “Pharmaceutical Development” [6], the principles for building quality into products are 
stated. Real-time release of pharmaceutical products will be possible if quality of the whole process 
can be assured by real-time quality control. Q9 “Quality Risk Management” [7] explains the general 
quality risk assessment and management process and gives examples of possible risk management 
methods and tools. Naelepää et al. [9] recently showed the application of risk management tools to 
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reveal the critical parameters of a coating process. Q10, “Pharmaceutical Quality System” [8], 
describes a model for an efficient quality management system for the pharmaceutical industry, 
based on International Standards Organization (ISO) quality concepts. The present study aimed at 
applying elements of these five guidelines on a continuous pharmaceutical granulation process.  
Gamlen and Eardley [10] were the first in 1986 to describe the advantages of continuous processing 
compared to batch processing. They used a continuous extruder, equipped with two helical mixing 
blades, for the production of paracetamol extrudates. Lindberg et al. [11] used a twin screw extruder 
to granulate. Both powder flow rate and liquid flow rate were regularly tested, but not persistently 
controlled and monitored. The group of H. Leuenberger (University of Basel) developed a semi-
continuous agglomeration process, consisting of a high shear granulation mixer and a fluid bed 
dryer. This system produced mini-batches in a quasi-continuous way [1, 3, 12, 13]. The terminology 
‘quasi-continuous manufacturing’ is used here, since the process principle is based on the 
granulation of small portions of powder in a high shear mixer. After the first portion is granulated, it 
is discharged to the fluid bed dryer and a second portion is filled into the mixer. This process can 
hence be considered as a fast succession of mini-batches, but not as a continuous stream of 
granules. 
As wet granulation is a commonly used unit operation within the pharmaceutical industry to 
improve compactibility and/or flowability of powder mixtures prior to tabletting, several continuous 
wet granulation techniques were developed which have been reviewed by Vervaet and Remon  [14, 
15]  Their co-workers [16-19] developed a continuous twin-screw granulator, which is now 
implemented in the commercially available ConsiGma™-system (GEA Pharma Systems nv., Collette™, 
Wommelgem, Belgium). Systems producing 25, 50 and 100 kg of granules per hour are commercially 
available. 
This study focused on a high shear twin-screw granulator, being the granulation unit of the 
ConsiGma™-25 continuous production line. Several equipment, formulation and process factors can 
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affect the quality of granules manufactured via this technique which will affect further downstream 
processing, such as the fluid-bed drying and tabletting process step. The continuous granulator 
parameters were scheduled (Table 1) after Aulton and Banks [20], who listed parameters of a fluid-
bed granulation process in three categories: equipment variables, process variables and product 
variables. Kristensen and Schaefer used the same categories with emphasis on both fluid-bed and 
high shear mixing-granulation [21].  
An evaluation of the equipment, process and formulation parameters having a significant influence 
upon the critical granule properties is needed in order to find the optimal process conditions. 
Traditionally, such evaluations are done by trial-and-error, i.e. changing one separate variable at a 
time (COST-approach). Since this is a time- and product-consuming approach, which does not 
guarantee finding the optimum conditions [22], the PAT and ICH guidelines recommend the 
application of organized methods (e.g. design of experiments, DoE) to define the relationship 
between parameters and quality of the end-product. 
A model formulation containing theophylline anhydrate and lactose monohydrate was used to 
monitor the wet granulation process.  Four different polymorphs of theophylline are known: 
theophylline monohydrate (TH), a metastable form of theophylline and two types of anhydrous 
forms, one stable at room temperature (TA) and one only occurring at very high temperatures [23].  
Pharmaceutical processes can induce (undesired) solid state transformations. Knowledge of the solid 
state of the API during processing  and storage is of the highest importance to assure a safe drug 
product. Changes in solid state can influence the chemical and physical properties of API’s, resulting 
in different processability (compressibility and powder flow), but also solubility, stability and 
bioavailability [24].  Norvir, an anti-HIV medicine, was already on the market when in 1998 a 
polymorphic transformation to a less soluble form of ritonavir was detected [25].  This product had 
to be reconstituted by the patient, but the dissolution of the capsules failed.  Airaksinen et al. [26] Gewijzigde veldcode
and Wikström et al. [27] studied the conversion of anhydrous theophylline into theophylline 
monohydrate using a planetary mixer and a high-shear mixer granulator, respectively.   
The aim of this study was to evaluate which granule properties can be monitored in-line using 
several PAT-tools (Raman and NIR spectroscopy and a particle size analyzer) during a continuous wet 
granulation process  in the granulation module of the ConsiGma™-25 unit.  Furthermore, a DoE was 
applied to examine the influence of several process and formulation settings upon the granule 
quality attributes, which were measurable using the implemented PAT tools.  
Materials and methods 
Materials 
Anhydrous theophylline (Fagron Iberica, Barcelona, Spain) (30%, w/w) was granulated with lactose 
monohydrate 200 M (Caldic Belgium NV, Hemiksem, Belgium). Polyvinylpyrrolidone (Kollidon 30, 
BASF, Burgbernheim, Germany) was added as binder to the dry powder mixture in a concentration 
of 2.5% (w/w). Distilled water was used as granulation liquid. Sodiumlaurylsulfate (Fagron, 
Waregem, Belgium) was added to the granulation liquid (0.5% w/v) to improve the wettability of the 
dry powder mixture. 
Methods 
Wet twin-screw granulation  
All granules were produced using the ConsiGma™-25 unit (GEA Pharma Systems nv., Collette™, 
Wommelgem, Belgium) (Figure 1a), which consists of three major parts: a continuous twin screw 
high shear granulator, a six parallel cell fluid bed dryer and a discharge system.  After discharging, a 
lubricant can be added and blended into the dried granules, after which this mixture can be 
compressed using an inline tabletting machine. 
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The continuous granulator unit consists of a barrel with two segments: a feed segment and a work 
segment, in which the powder is mixed, wetted and granulated. The dosing unit (Figure 1a-(1)) feeds 
the powder into the granulator (2) in a loss-in-weight-controlled manner. The granulation liquid is 
fed out of a granulation liquid vessel (3)  into two injection nozzles, mounted in the work segment of 
the granulator, using a loss-in-weight peristaltic pump. The temperature of the work segment can be 
controlled by a temperature control unit. The wet granules leave the granulator unit through the 
discharge element of the barrel. The continuously produced wet granules are pneumatically 
transferred to the six-segmented fluid bed dryer (4). In these segments, the granules are dried by 
hot air, whose flow and temperature can be controlled. After a set drying time period the granules 
are subsequently extracted from the drying segment trough a rotational outlet valve. The dry 
granule output is transferred to a product control hopper (5). Granules are then gravitationally 
transferred to a mill inlet, which is fed at constant flow by a metering valve. The granules are 
unloaded gravitationally, after which they can be blended with a lubricant and tabletted. 
This study  focuses on the continuous twin-screw granulator. The screw configuration was kept 
constant for all experiments (Figure 1b). The influence of the granulator configuration upon the 
granule properties will be evaluated in future studies. The screws consisted of a long transport zone 
and two kneading zones of six kneading elements in an angle of 60°. These two kneading zones were 
separated from each other by a short transport element, with the same length as a kneading zone. 
Wet granules were unloaded, from the barrel via another identical short transport element.  
Several process parameters can be set for continuous wet granulation (Table 1, 4th column). In this 
study, bridge breaker speed was held constant at 80%. One of the assets that ConsiGma™ offers is 
the automatic logging, trending and storage of several process parameters (e.g., temperature 
granulator barrel, weight powder dosing unit, mass flow granulation liquid etc.). 
 
 
Twin-screw granulation process monitoring 
An in-house made cuvet was placed under the granulator outlet to collect the granules (Figure 2). 
The cuvet was a box of 10 cm x 10 cm, having a height of 15 cm. One side contained several 
interfacing places where the NIR diffuse reflectance contact probe could be introduced, while the 
opposite side of the cuvet contained two interfacing places for the MR Raman probe head. At the 
inner wall of the cuvet, the Raman probe interfacing holes were covered by quartz-glass, hence 
allowing non-contact measurements. This measurement setup ensured reproducible probe 
interfacing and sampling of non-moving granules, hence eliminating variation in the spectra due to 
variable probe positions. We are currently developing a measurement device for future studies 
which can be implemented in the transport lines between the different units of the ConsiGma™. This 
measurement device will allow, similarly as for the cuvet used in this study, static Raman and NIR 
spectroscopic measurements (as interaction between light and non-moving solids is much more 
understood) and dynamic Parsum measurements.  
Since the equipment produces mainly fines in the start-up phase, the granules produced during the 
first minute of each granulation experiment were considered as waste and removed. After this first 
minute, granules were collected in the cuvet for three minutes.  
Raman - Spectroscopy 
A RamanRxn1 spectrometer (Kaiser Optical Systems, Ann Arbor, Michigan), equipped with an air-
cooled CCD detector (back-illuminated deep depletion design) was used. A fiber-optic non-contact 
probe was placed against the quartz glass at the inner wall of the cuvet in which granules were 
collected. Spectra were taken via the different interfacing places of the cuvet. The laser wavelength 
was the 785 nm line from a 785 nm Invictus NIR diode laser. All spectra were recorded with a 
resolution of 4 cm-1 and an exposure time of 30 seconds, using a laser power of 400 mW. Data 
collection and data transfer were automated using the HoloGRAMS™ data collection software, the 
HoloREACT™ reaction analysis and profiling software and the Matlab software (version 7.1, The 
MathWorks Inc., Natick, Massachusetts).  
NIR - Spectroscopy 
A Fourier-Transform NIR spectrometer (Thermo Fisher Scientific, Zellik, Belgium, Nicolet Antaris II 
near-IR analyzer) equipped with an InGaAs detector, a quartz halogen lamp and a fiber optic contact 
probe was used. Spectra of each granulation experiment were taken, through each of the four 
interfacing places in the cuvet. The probe was mounted into the cuvet in exactly the same way for 
every measurement. Hence, measurements could be done in a reproducible way. Each spectrum 
was collected in the 4500 - 10000 cm−1 region with a resolution of 16 cm−1 and averaged over 16 
scans. Data collection and data transfer were done using Thermo Fisher Scientific’s Result Software.  
In-line Particle Size Analysis 
An In-line Spatial Filter Velocimetry probe (Parsum®, Chemnitz, Germany) was used to continuously 
monitor the particle size of the granules in-process. The probe consisted of a semiconductor laser 
diode, which radiated visible light at a wavelength of 670 nm.  Furthermore the measurement probe 
was provided with an integrated air-cleaning system to keep the optical surfaces clean. The 
applicability and technical details of SFV are extensively described in literature [28]. The probe was 
placed 10 cm under the granulator outlet and in-line measurements were started after one minute. 
At the beginning of each granulation experiment one can choose virtual 'sieves', which are the 
ranges that will be used to calculate the particle size distribution. In this study, the virtual sieves 
were 150 µm, 250 µm, 500 µm, 710 µm, 1000 µm, 1400 µm, 2000 µm, 3150 µm, 5000 µm and 7500 
µm and the particle size distribution was calculated in real-time every five seconds. A shortfall of the 
Parsum system is that once the particle size distribution ranges are chosen, they cannot be adjusted 
during the process. This means that prescience on the particle size distribution of the investigated 
granules is required before starting the SFV measurements.  All measurement values were 
continuously stored and visualized in real-time by the IPP 70 software. Data analysis was done using 
the V 1.6 Macro in Excel 2007. 
Design of Experiments (DOE) 
A 2-level full factorial design was applied to study the influence of four process variables upon both 
the solid state and particle size (D50) of the wet granules (i.e. 2^4 + 3 = 19 granulations 
experiments). The screw speed was varied between 600 and 950 rpm. The temperature of the 
granulator barrel was altered between 25°C and 40°C. The liquid concentration was varied between 
8.38% and 9.94% (w/w). The premixed powder was fed in a range from 10 to 25 kg per hour (Table 
2). Both the powder feed rate and screw speed determine the barrel filling degree. The center point 
experiment of the design was repeated three times. All equipment variables (Table 1) were kept 
constant. The excipients, API and granulation liquid were the same for all experiments. All 
performed DOE granulation experiments are listed in Table 2. 
Data-analysis 
The results of the DOE granulation experiments were analyzed using Modde 9.0 (Umetrics, Umeå, 
Sweden).  Simca P+ 12.1 (Umetrics, Umeå, Sweden) was used for principal component analysis (PCA) 
of the NIR and Raman spectra collected during all granulation experiments. The spectral data were 
Standard Normal Variation (SNV) corrected for baseline-correction and for neutralizing differences in 
particle size and packing of the granules before applying PCA.   
Results and Discussion 
One characteristic of the ConsiGma™-25 is that all continuously produced wet granules are 
transferred to the fluid bed dryer. Granules which are not meeting the predetermined specifications 
cannot be removed, as is possible for batch production systems. Since batches are inspected after 
production and off-line tests are performed, bad batches can be rejected and will not be processed 
to the next production step. Therefore knowledge and control of the critical characteristics of the 
granules is important to guarantee appropriate downstream processing. 
Particle size 
The in-line particle size analyzer (Parsum®, Chemnitz, Germany) gives a very rapid image of the 
particle size distribution of the continuously produced wet granules. However, during the DoE 
experiments, sticking of the wet granules to the probe window (fouling) was observed despite the 
integrated air-cleaning system. Therefore, only these distributions in which no fouling was seen were 
extracted from all obtained distributions per DoE experiment (every 5 s during 3 minutes) for further 
interpretation. For future studies and more detailed wet granule size distribution evaluation, we will 
first need to examine whether fouling can be avoided by optimizing the probe interfacing and 
cleaning system. Therefore in this study, only the D50 values from the selected distributions were 
evaluated to observe some trends how the examined parameters influence the granule size. A 
representative example of a selected particle size distribution obtained during DoE experiment 4 is 
shown in Figure 3. The D50 (50 % of the distribution has a particle size smaller than this value) 
obtained after two minutes of measurements was used as the DOE-response value. Table 2 gives an 
overview of the D50’s after two minutes of production for all DOE-experiments. The influence of the 
process variables upon the D50 is evaluated in the effect plot, shown in Figure 4. Both the powder 
feed rate and the temperature of the barrel have a significant and positive influence on the D50. 
Increasing the powder feed rate and increasing the barrel temperature result in large and oversized 
granules. Also, a significant interaction between these two factors was found. A higher powder feed 
rate will result in a higher compaction of the powder in the granulator barrel and thus larger 
granules. A higher temperature of the granulator barrel will induce a higher solubility of lactose, 
theophylline and PVP and consequently more bridge formation. Adding more granulation liquid 
tends to generate larger granules, but only a small range of the amount of added liquid was 
investigated in this study. Experiments 2, 9 and 19 illustrate these findings, as these three runs 
produced very large granules (Table 2). Experiments 1, 4, 6, 12 and 18 produced the smallest 
granules, as granulation was done using a low powder feed rate (10 kg/hour) and (except for run 18) 
a cold granulator barrel.  
Overall it can be stated that none of the produced wet granules are satisfactory regarding particle 
size. The produced granules are too large to obtain good tablets after compression, but some 
remarks should be made. First off all, this is a measurement of wet granules, the particle size of the 
granules may reduce during drying. Furthermore the ConsiGma™-25 is equipped with a discharging 
unit, which contains a mill to grind oversized granules. Nevertheless, the aim should be to fully 
understand, monitor and control the granulation and drying process, so that granules with an ideal 
particle size distribution are obtained and the mill will be redundant.  
 
Solid State 
Raman spectroscopy 
Wikström et al. [27]  found that Raman spectroscopy is an efficient tool to differentiate theophylline 
monohydrate from anhydrous theophylline, and that the conversion can be followed in real-time. 
The spectrum (Figure 5) of TA  has two intense peaks at 1664 and 1706 cm-1, whereas TH has a peak 
at 1686 cm-1, which is due to C=O stretch of the carbonyl-groups. Furthermore during hydrate 
formation the O==C—N band shifts from 555 cm-1 to 572 cm-1 [29].  The excipients in the studied 
formulation have no overlapping Raman signal in these regions. 
Principal component analysis of all spectra collected during the 19 DOE experiments was performed. 
The spectral regions from 520 cm-1 to 600 cm-1 and from 1636 cm-1 to 1737 cm-1 were selected and 
modeled together, as the solid state information is available in these spectral regions. Three 
principal components described 99.4% the spectral variation. The first, second and third PC 
explained 78.62%, 14.37% and 6.41%, respectively. A PC 1 versus PC 2 scores plot was plotted, and 
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information regarding the solid state can be seen along the PC2-axis. Secondary observation 
identifiers (i.e., the applied colors in the scores plots) were assigned to each individual spectrum 
(score) in order to classify them after used screw speed, barrel temperature, liquid concentration 
and powder feed rate. When classifying spectra according to the amount of added granulation liquid 
(Figure 6a; the red triangles correspond to the spectra collected from the DOE experiments where 
8.38% (w/v) granulation liquid was used, the green crosses to 9.16% (w/v) and the blue squares to 
9.94 % (w/v)), clustering can be noticed in the scores plot. Granules, which were produced with a 
low concentration of granulation liquid, are mainly situated in the positive part of the PC2, whilst 
those granulated with a high amount of liquid are situated in the negative part. Classification 
according to the applied barrel temperature (Figure 6b) shows, that granules produced in a barrel 
heated to 40°C result in spectra mainly clustered in the positive half of the PC 2. Granules produced 
using a cold barrel (25°C) can be found in the negative part of PC 2. Concerning the powder feed 
rate, the positive part of the PC2 contains most of the runs, where a powder feed rate of 25 kg/hour 
was used (Figure 6c). When data were classified after screw-speed, no clustering could be seen in 
the scores plot. 
To find an explanation for these clusterings, one should take a look at the loadings plots. No solid-
state clustering can be seen along the PC1-axis from the scores plots, but only along the PC2-axis. 
This indicates that the variation in solid state is expressed by PC 2. The loadings plot of the first 
principal component shows basically the joint spectra of theophylline monohydrate and anhydrous 
theophylline.  The variation captured by PC 1 is most probable due to altering measurement 
conditions between the different analyzed samples (e.g., differences in probe to sample distances, 
differences in physical properties and granule sizes of the different samples etc.). More interesting is 
the loadings plot of the second principal component (Figure 7). Maxima are found at 555 cm-1, 
1665.6 cm-1 and 1707.6 cm-1, whereas minima are found at 574.2 cm-1 and 1687.5 cm-1. Both minima 
can be attributed to theophylline monohydrate, while the three maxima can be assigned to 
anhydrous theophylline. Hence, experiments where the spectra are clustered in the positive part of 
the PC2-axis contain a quantity of remaining anhydrous theophylline. These experiments are listed in 
Table 3.  
It is clear that water, and a certain water activity is needed for the conversion of anhydrous 
theophylline to theophylline monohydrate. Hence, the presence of remaining anhydrous 
theophylline can be explained for the runs with lower liquid concentration. Adding less water, which 
results in a lower water activity,  leads to a lower conversion rate of anhydrous theophylline to 
theophylline monohydrate [30, 31]. 
Ticehurst et al. [30] stated that at higher temperature an increased water activity is required to 
transform anhydrous theophylline to theophylline monohydrate. This can explain why runs with a 
higher barrel temperature result in these small remaining amounts of anhydrous theophylline in the 
granules. Furthermore hydration is an exothermic process, which means adding energy by means of 
heat will shift the reaction towards the anhydrate form [32]. 
With a high barrel filling the granulation liquid will have more difficulties to spread well through the 
powder bed, this can be an explanation of remaining anhydrate when granulating at 25 kg/h. 
Furthermore a high barrel filling will result in larger granules (as stated earlier), which makes it 
harder for the granulation liquid to penetrate in the granules. 
Raman spectroscopy together with Design of Experiments showed to be valuable tools to investigate 
and understand solid state transformations in wet granules. Even small amounts of a non-expected 
polymorph can be detected. 
NIR spectroscopy 
To investigate if the same conclusions can be made when analyzing the granules with NIR 
spectroscopy, runs 6 till 19 were taken into account (runs 1 till 5 were not taken into account, since 
inadequate NIR spectra were obtained due to sampling problems). PCA was performed on the 
complete spectral range (10000 to 4500 cm-1) resulting in three principal components. These 
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explained 97.1 % of the variation. PC 1 explained 69.11 % of the spectral variation, PC 2 18.82% and 
PC 3 9.13 %. In order to make a distinct classification possible, secondary observation identifiers (i.e., 
assignment of colors, which are corresponding to certain process settings, to the scores) were added 
to all spectra. 
The first principal component differentiates the granulation experiments after water content (Figure 
8a). Granules produced with a high liquid amount are spread along the positive part of the PC 1-axis, 
while those produced with a low liquid amount can be found in the negative part of PC 1.  This is 
confirmed by the loadings of this first principal component, which clearly shows two water bands 
(Figure 8b). The spectral band at 5222 cm-1 corresponds to the OH-stretching and bending vibrations 
of water molecules, while the 7035 cm-1 band can be attributed to first overtone OH-stretching 
vibrations. Two more vibration are contributing to these peaks, resulting in two shoulders at 6880 
cm-1 and 5168 cm-1. These two bands are caused by lactose monohydrate [33]. 
In Figure 9a, the PC 2 versus PC 3 scores plot was plotted and data were labeled and examined after 
secondary observation identifiers. Most spectra of the granules produced with a low concentration 
of granulation liquid can be found in the positive part of the PC 3-axis. The same trend can be seen 
for granules produced in a warm granulation barrel  (Figure 9b). Classifying data after powder feed 
rate or screw speed did not result in any clear clustering. 
The loadings plot of PC 3 (Figure 9c) shows an absorption band of OH vibrations at 7035 cm-1. This 
water-bond is oppositely directed, compared to the bands at 5947 cm-1 and 6009 cm-1, which are 
specific peaks for anhydrous theophylline. Furthermore, a remarkable peak at 5168 cm-1 can be 
attributed to lactose monohydrate, which has the same concentration in all granules [33]. NIR 
confirms hence the Raman analysis findings. The granulation experiments corresponding to the 
scores in the positive part of the PC3-axis most likely contain remaining anhydrous theophylline. NIR 
only shows the variation in solid state, when different barrel temperatures or liquid concentrations 
are applied. 
An overview of the runs containing an amount of anhydrous theophylline is given in Table 3. Runs (6-
19) which were thought to contain anhydrous theophylline when investigated with Raman are all 
confirmed by NIR. 
Conclusions 
This study gave an insight in the possibilities of implementing PAT-tools in a continuous twin-
screw granulation process. Both Raman and NIR showed to be appropriate tools for understanding 
the solid state behavior of theophylline during wet granulation. Peak differentiation and polymorph 
differentiation was more definite in Raman spectra than in NIR spectra. 
The In-Line Particle Probe showed to be a promising tool for the in-line measurement of particle size 
distribution. More investigation on the measurement technique will be necessary to obtain 
adequate measurements of wet granules. The main challenge is to avoid fouling of the optical 
surfaces. 
Performing a DOE, allowed to reveal the most influencing granulation parameters upon granule size 
and the solid state of the API. The temperature of the barrel and the added amount of granulation 
liquid, and to a lesser extent the powder feed rate showed to have an effect upon the solid state of 
the wet granules. The powder feed rate and the barrel temperature had significant effects upon the 
granule size. 
This paper proves that at-line measurements of both solid state and particle size during a continuous 
twin-screw granulation process are feasible. Given these promising results of the presented tools, 
the next step will be the design of a new process analyzer interfacing device. This device should 
permit integration of PAT-tools in the ConsiGma™-25, allowing them to provide real-time 
information. Future studies will focus on the use of the in-line measured critical process and product 
information to steer the next process steps (e.g., feed forward adjustment of process settings of 
further process steps). 
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Tables 
Equipment Variables Product Variables Process Variables 
  Starting Powder Properties Liquid Characteristics   
Screw configuration Particle size distribution Viscosity Powder feed rate 
Screw length Homogeneity of raw material powders Surface tension Bridge breaker speed 
Length- to-diameter ratio of the screws Presence of agglomerates in premix  Solid-liquid tension Filling degree of barrel 
Diameter of the granulation liquid inlet 
nozzels Segregation during feeding 
 
Screw speed 
 
Powder density 
 
Barrel temperature 
Powder feeding method Cohesion Binder type Liquid feed rate 
Place of liquid addition into barrel  Particle shape Binder concentration   
 
Surface roughness Binder  addition method (wet/dry) Powder feed rate 
  Surface area  
 
  
  Solubility in granulation liquid 
 
  
  Hygroscopicity 
 
  
  Wettability 
 
  
    
 
  
  API/excipient quantitative ratio 
 
  
  
  
  
  Concentration     
Table 1: Equipment, Product and Process Variables influencing the characteristics of a continuous twin-screw granulation process. 
 
 
 
Run Order Screw Speed 
Powder Feed 
Rate Water Content Barrel T D50 
  (rpm) (kg/h) (%) (°C) (µm) 
1 950 10 8,38 25 2397 
2 600 25 9,94 40 5793 
3 950 10 9,94 40 3299 
4 950 10 9,94 25 2521 
5 950 10 8,38 40 3650 
6 600 10 9,94 25 2843 
7 775 17,5 9,16 32,5 3787 
8 950 25 8,38 40 3966 
9 950 25 9,94 40 6153 
10 600 25 8,38 25 2463 
11 950 25 9,94 25 3188 
12 600 10 8,38 25 2051 
13 600 25 9,94 25 3053 
14 600 10 9,94 40 2437 
15 775 17,5 9,16 32,5 3124 
16 950 25 8,38 25 3227 
17 775 17,5 9,16 32,5 3097 
18 600 10 8,38 40 2383 
19 600 25 8,38 40 4137 
Table 2. Overview of the design experiments – Calculated D50 values obtained after two process minutes. 
 
 
 
Run Water Content Barrel T Powder Feed Rate Raman NIR 
  Dry - (8,38%) Hot - (40 °C) Full - (25kg/h)     
1 X         
2   X X +++   
3   X   +++   
4           
5 X X   +++   
6           
7   
 
      
8 X X X +++ +++ 
9   X X +++ +++ 
10 X    X     
11     X     
12 X         
13   
 
X     
14   X        
15   
 
      
16 X 
 
X +++ +++ 
17   
 
      
18 X X    +++ +++ 
19 X X X +++ +++ 
Table 3. Overview of all DOE granulation experiments. Both significant parameters and spectroscopic responses are listed. Runs in which Raman and/or NIR-
spectroscopy show the presence of anhydrous theophylline are indicated with +++. 
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Figure captions 
Figure 1a. ConsiGma™-25  
(1) Continuous feeder  - (2) Continuous twin screw high shear granulator – (3) Granulation Liquid 
Vessel - (4) Six parallel cell fluid bed dryer – (5) Product control hopper  with integrated mill 
Figure 1b. Screw configuration of the twin screws. 
Figure 2. In-line twin-screw granulation monitoring. An in-line Spatial Filter Velocity probe (Parsum®) 
was placed under the outlet of the granulator and above the cuvet, allowing the dynamic 
measurement of particle size distribution from the produced granules. A Raman probe and an NIR- 
probe were implemented at several locations in the cuvet allowing static measurements of the 
granules. 
Figure 3. Particle size distribution observed during DOE experiment 4. 
Figure 4. Effect plot of the response variable D50.  
PowFR: Powder feed rate; BarT: Temperature of the granulator barrel; Liq: Granulation liquid 
concentration; ScrSp: Screwspeed 
Figure 5 : SNV-corrected Raman spectra of anhydrous theophylline (full line) and theophylline 
monohydrate granules (dashed line) in lactose 
Figure 6a. Raman spectra: PC 1 (78.62 %) versus PC 2 (14.37 %) scores plot  (a) colored according to 
concentration of added granulation liquid. Red triangles – 8.38 %; blue squares – 9.94 %; green 
crosses centerpoints – 9.16%.  
Figure 6b. Raman spectra: PC 1 (78.62 %) versus PC 2 (14.37 %) scores plot (b) colored according to 
the applied temperature of the barrel. Red triangles – 40°C; blue squares – 25°C; green crosses 
centerpoints – 32.5 °C. 
Figure 6c. Raman spectra: PC 1 (78.62 %) versus PC 2 (14.37 %)  scores plot (c) colored according to 
powder feed rate. Red triangles – 25 kg/h; blue squares – 10 kg/h; green crosses centerpoints – 17.5 
kg/h. 
Figure 7. Raman spectra: Loadings plot of the second principal component (14.34 %) 
Figure 8a. NIR spectra: PC 1 (69.11 %) versus PC 2 (18.82 %) scores plot: (a) colored according to 
added granulation liquid amount. Red triangles – 8.38 %; blue squares – 9.94 %; green crosses 
centerpoints – 9.16%. 
Figure 8b. NIR spectra: Loadings plot of the first principal component (69.11 %). 
Figure 9a. NIR spectra: PC 2 (18.82 %) versus PC 3 (9.13 %) scores plot (a) colored according to 
concentration of added granulation liquid. Red triangles – 8.38 %; blue squares – 9.94 %; green 
crosses centerpoints – 9.16%.   
Figure 9b. NIR spectra: PC 2 (18.82 %) versus PC 3 (9.13 %) scores plot (b) coloured according to the 
applied temperature of the barrel. Red triangles – 40°C; blue squares – 25°C; green crosses 
centerpoints – 32.5 °C. 
Figure 9c. NIR spectra: Loadings plot of the third principal component  (9.13 %)  with a zoom on the 
6310 cm-1-4800 cm-1 region.
  
